Keya Medical

AI for Smarter Healthcare

Keya Medical Raises Over $20 Million in Series B+ Financing Round

Keya Medical

Keya Medical was founded in 2016 to harness artificial intelligence to develop innovative diagnostic products that improve healthcare. Collaborating with leading healthcare systems in North America, Europe, and Asia, Keya Medical provides AI-enabled technology that helps medical professionals deliver better care. 


DEEPVESSEL FFR* uses deep learning technology to perform a non-invasive physiological functional assessment of the coronary arteries using coronary CT angiogram scans. The software reduces unnecessary invasive testing to lower costs and complications.

*CE Marked, National Medical Products Administration (NMPA) Approved. Not for sale in the United States.

DeepVessel Certification 2020

DEEPVESSEL FFR Approved for Clinical Use in China

On January 15, 2020, the National Medical Products Administration (NMPA) in China issued the registration certificate approving DEEPVESSEL FFR for clinical use.


Coronary Analysis and Reporting System
*The following product is in development and has not been reviewed by the FDA. This product is not for sale in the US.

Who do we work with

Healthcare Delivery

Keya Medical is committed to developing medical imaging AI solutions in collaboration with healthcare providers. Since 2016, we have worked with more than 200 hospitals around the world.


Keya Medical is continuing to develop new solutions to improve cardiovascular disease diagnosis and treatment. We invite payers to continue the conversation on how our solutions can create savings.


Keya Medical is funded by visionary investors who want to make a positive social impact and benefit from the potential expansion of medical AI.

Start a collaboration with Keya Medical

Latest News